Fig. 8
From: Exploring bioactive phytoconstituents as USP21 inhibitors for therapeutic development against cancer
Free energy landscapes for (A) USP21, (B) USP21-Ranmogenin A, (C) USP21-Tokorogenin, and (D) USP21-BAY-805.
Fig. 8 | Scientific Reports
From: Exploring bioactive phytoconstituents as USP21 inhibitors for therapeutic development against cancer
Free energy landscapes for (A) USP21, (B) USP21-Ranmogenin A, (C) USP21-Tokorogenin, and (D) USP21-BAY-805.
